Wolverine Trading’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-13,884
Closed -$438K 5386
2020
Q3
$438K Sell
13,884
-612
-4% -$19.7K ﹤0.01% 2960
2020
Q2
$407K Buy
+14,496
New +$409K ﹤0.01% 2974
2020
Q1
Sell
-8,140
Closed -$257K 5177
2019
Q4
$257K Buy
+8,140
New +$228K ﹤0.01% 3781
2018
Q4
Sell
-15,000
Closed -$436K 5215
2018
Q3
$436K Buy
+15,000
New +$394K ﹤0.01% 3275
2018
Q1
Sell
-15,080
Closed -$333K 5733
2017
Q4
$333K Sell
15,080
-556
-4% -$12.1K ﹤0.01% 3476
2017
Q3
$334K Buy
+15,636
New +$321K ﹤0.01% 3118

Other funds holding RXL

Wolverine Trading's RXL Position: Q4 2020 in Review

Wolverine Trading sold out of ProShares Ultra Health Care (RXL) in Q4 2020, closing a stake of 13,884 shares — an estimated $438K sold.

Wolverine Trading first reported a position in RXL in Q3 2017 and held it in 6 quarters. The position peaked at $438K in Q3 2020. 17 funds tracked by Wall St. Rank hold RXL as of Q4 2020.

  • Wolverine Trading reported no remaining ProShares Ultra Health Care position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 13,884 ProShares Ultra Health Care shares in Q4 2020, an estimated $438K.
  • Wolverine Trading first reported a position in ProShares Ultra Health Care in Q3 2017 and held it in 6 quarters.
  • Wolverine Trading's ProShares Ultra Health Care position peaked at $438K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.